immunogenicity and safety of Imovax Polio [poliovirus vaccine live oral] in Chinese infants compared to local OPV

Trial Profile

immunogenicity and safety of Imovax Polio [poliovirus vaccine live oral] in Chinese infants compared to local OPV

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2014

At a glance

  • Drugs Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine live oral (Primary)
  • Indications Poliomyelitis
  • Focus Pharmacodynamics
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2008 Planned end date 1 Dec 2008 added as reported by ClinicalTrials.gov
    • 24 Sep 2008 Primary endpoint amended as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top